Trial Profile
Cethromycin in patients hospitalized with moderate-to-severe community-acquired bacterial pneumonia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2010
Price :
$35
*
At a glance
- Drugs Cethromycin (Primary)
- Indications Bacterial infections; Community-acquired pneumonia
- Focus Therapeutic Use
- Sponsors Advanced Life Sciences
- 10 Nov 2010 New trial record